Central Nervous System (CNS) disorders remain among the most complex and urgent challenges in global healthcare. This session will spotlight the latest advancements in CNS research and development, highlighting breakthroughs in areas that are revolutionizing our approach to these devastating diseases. Join a panel of leading experts from biotech, pharma, and the investor community as they share cutting-edge approaches and discuss how the convergence of technology accelerates the path from discovery to treatment. The discussion will cover disease-modifying approaches in neurodegeneration, translational precision in CNS R&D and how advances in platform technologies are enabling more efficient development of next-generation CNS therapies. This session offers a deep dive into the challenges and opportunities in the CNS landscape, providing a forward-looking perspective on the innovative strategies paving the way for a new era of brain health.